4.5 Article

Risk of Endometrial Cancer in Women With Pelvic Inflammatory Disease A Nationwide Population-Based Retrospective Cohort Study

期刊

MEDICINE
卷 94, 期 34, 页码 -

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MD.0000000000001278

关键词

-

资金

  1. Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]
  2. China Medical University Hospital
  3. Academia Sinica Taiwan Biobank
  4. Stroke Biosignature Project [BM104010092]
  5. NRPB Stroke Clinical Trial Consortium [MOST 103-2325-B-039 -006]
  6. Tseng-Lien Lin Foundation (Taichung, Taiwan)
  7. Taiwan Brain Disease Foundation (Taipei, Taiwan)
  8. Katsuzo and Kiyo Aoshima Memorial Funds (Japan)

向作者/读者索取更多资源

To investigate the association between pelvic inflammatory disease (PID) and endometrial cancer (EC).We conducted a nationwide population-based retrospective cohort study, and data were obtained from the National Health Insurance Research Database. We defined 41,065 patients with PID as the PID cohort and 82,130 randomly selected patients as the control cohort through frequency matching by age and index year. PID and EC were diagnosed in accordance with the International Classification of Diseases, Ninth Revision, and Clinical Modification. Cox proportional hazards regression and Kaplan-Meier method were used in the analysis.Incidence rates of 16.1 and 9.6 per 100,000 person-years and mean follow-up durations of 4.84 and 6.63 years were observed in the PID and non-PID cohorts, respectively. After adjusting for potential risk factors, the PID cohort had a 1.79-fold higher risk of developing EC than the non-PID cohort. The incidence of EC increased with age, particularly for those aged >50 years (HR=2.45, 95% CI=1.29-4.65). Higher EC risk was also observed in the PID cohort with hypertension than in the non-PID cohort.The results of this large-scale population-based study showed an increased risk of EC in PID patients, particularly in older patients or those with hypertension. Future large-scale clinical trials are warranted to clarify the function of medication in PID-related EC progression.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据